Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AGMB will decline by -3.05% over the next 2 Weeks and hit $9.70 by Monday, June 29, 2026. In that time frame, AGMB's share price is expected to range between $8.85 and $10.62.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 30, 2026 | 8.81 | 9.60 | 10.50 |
| Jun 29, 2026 | 8.94 | 9.81 | 10.66 |
| Jun 26, 2026 | 8.73 | 9.58 | 10.44 |
| Jun 25, 2026 | 8.73 | 9.64 | 10.50 |
| Jun 24, 2026 | 9.10 | 9.95 | 10.79 |
| Jun 23, 2026 | 8.91 | 9.75 | 10.56 |
| Jun 22, 2026 | 9.11 | 9.96 | 10.77 |
| Jun 19, 2026 | 8.85 | 9.73 | 10.61 |
| Jun 18, 2026 | 8.86 | 9.79 | 10.59 |
| Jun 17, 2026 | 9.25 | 10.10 | 10.97 |
AGMB shares remained flat 0 in Tuesday, June 16, 2026's trading session, starting and closing at a previous close of $10.00 to move at $10.00. The stock demonstrated notable intraday movement (see AGMB's key stats for a full breakdown), fluctuating between $9.79 and $10.45, a +6.80% trading range. While recent weeks have seen some volatility, AGMB has managed to secure a -16.67% drop over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 102.68K shares changing hands, 57.15K fewer than the previous session. This amounted to $1.03M in total market activity.
Will AGMB Continue Its Upward Trend?
According to analyst ratings and projections for AGMB, AgomAb Therapeutics N.V. American Depositary Shares shares are anticipated to increase by +4.78%, potentially reaching $10.50 per share by June 30, 2026. Short-term technical indicators currently suggest a neutral sentiment for AGMB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the AGMB stock forecast, now is a good time to buy AGMB stock because its current trading price is +4.18% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on AGMB covering social and institutional perspectives.
AGMB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AGMB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 41.38% to 43.62%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.03%, suggests a neutral medium-term outlook. Insights into AGMB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
AgomAb Therapeutics NV American Depositary Shares Short-Term Forecasts
AGMB Forecast For Next 5 Days
Our algorithm anticipates AgomAb Therapeutics NV American Depositary Shares (AGMB) stock could hit $9.58 by Jun 23, 2026. This represents a -4.16% fall from today's price, following a - change over the past five days.
AGMB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for AgomAb Therapeutics N.V. American Depositary Shares (AGMB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $8.84, which would mean a -11.60% decrease from the current price of $10.00. Projections for this period range from a high of $10.77 to a low of $6.95.
AGMB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for AgomAb Therapeutics NV American Depositary Shares's price over the next three months point to a rise. AGMB stock is expected to peak at $25.04 on Jun 22, 2026 before potentially dipping to $15.54 on Sep 11, 2026. On average, AGMB is likely to trade around $19.74 in the coming 90 days.
AgomAb Therapeutics NV American Depositary Shares Stock Forecast 2025
Based on our predictive models, AgomAb Therapeutics NV American Depositary Shares (AGMB) is expected to trade between $9.04 and $25.04 throughout 2026. This would result in an average price of $15.87, potentially offering investors a +58.70% return from current levels.
AgomAb Therapeutics N.V. American Depositary Shares Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is positioned to show a strong performance in June 2026. The price is predicted to move between $20.70 and $25.04, settling at an average of $23.25. This could translate to a +132.50% gain.
July 2026
Based on current market signals, AgomAb Therapeutics N.V. American Depositary Shares is projected to trend july 2026. We forecast a trading range from $20.17 to $22.83, with a likely average price of $21.42. Investors could expect a potential return of +114.20%.
August 2026
Our predictive algorithms indicate AgomAb Therapeutics N.V. American Depositary Shares stock may see a shift in August 2026. The expected range spans $16.16–$19.95, with an average target of $18.28. This represents a positive outlook and a possible gain of +82.80%.
September 2026
Analyzing established trends, AgomAb Therapeutics N.V. American Depositary Shares looks set to move in September 2026. Projections place the stock between $14.04 and $16.81, averaging around $15.64. This suggests a +56.40% gain from current levels.
October 2026
Market indicators suggest AgomAb Therapeutics N.V. American Depositary Shares could experience notable changes during October 2026. Prices could fluctuate within $12.77 to $15.93, with a midpoint forecast of $14.13. The stock might deliver a +41.30% gain.
November 2026
Forecasting for November 2026, models estimate that AgomAb Therapeutics N.V. American Depositary Shares may undergo key fluctuations. If trends hold, the stock might trade between $10.25 and $13.29, averaging $11.88. This signals a positive trajectory with potential returns around +18.80%.
December 2026
According to our latest forecast models, AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is positioned to show a strong performance in December 2026. The price is predicted to move between $9.04 and $11.65, settling at an average of $10.42. This could translate to a +4.20% gain.
January 2027
Based on current market signals, AgomAb Therapeutics N.V. American Depositary Shares is projected to trend january 2027. We forecast a trading range from $7.05 to $9.17, with a likely average price of $8.16. Investors could expect a potential return of -18.40%.
February 2027
Our predictive algorithms indicate AgomAb Therapeutics N.V. American Depositary Shares stock may see a shift in February 2027. The expected range spans $6.60–$7.57, with an average target of $7.09. This represents a cautious outlook and a possible loss of -29.10%.
March 2027
Analyzing established trends, AgomAb Therapeutics N.V. American Depositary Shares looks set to move in March 2027. Projections place the stock between $4.48 and $7.34, averaging around $5.73. This suggests a -42.70% loss from current levels.
April 2027
Market indicators suggest AgomAb Therapeutics N.V. American Depositary Shares could experience notable changes during April 2027. Prices could fluctuate within $3.45 to $4.60, with a midpoint forecast of $3.96. The stock might deliver a -60.40% loss.
May 2027
Forecasting for May 2027, models estimate that AgomAb Therapeutics N.V. American Depositary Shares may undergo key fluctuations. If trends hold, the stock might trade between $2.98 and $4.20, averaging $3.67. This signals a cautious trajectory with potential returns around -63.30%.
June 2027
According to our latest forecast models, AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is positioned to show a strong performance in June 2027. The price is predicted to move between $2.62 and $3.24, settling at an average of $2.98. This could translate to a -70.20% loss.
AGMB's history of dividends and stock splits also plays a role in long-term investor confidence.